Five Prime Therapeutics' Partnership - II Round

Five Prime Therapeutics raised a round of funding on May 08, 2008. Investors include Pfizer.

Five Prime Therapeutics is a clinical-stage biotechnology company with a pipeline of antibodies and ligand traps for cancer, autoimmunity and respiratory diseases. FivePrime has differentiated discove…

Articles about Five Prime Therapeutics' Partnership - II Round: